ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neurological Biomarkers

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1559688

Aberrant highly prokineticin 2 and its association with inflammatory indexes and functional recovery in acute ischemic stroke patients

Provisionally accepted
Lixiao  SunLixiao Sun1Yuxin  FuYuxin Fu1Jiecheng  YangJiecheng Yang2Xiaoli  WangXiaoli Wang1Dongsheng  CuiDongsheng Cui1Qiang  FengQiang Feng1Xuguang  SongXuguang Song1Zhe  LiZhe Li1Zhuangwei  WangZhuangwei Wang1Wenchao  WangWenchao Wang1Yiping  WuYiping Wu1Jingmei  WangJingmei Wang1*
  • 1HanDan Central Hospital, Handan, Hebei Province, China
  • 2Merice Cody Public School, Toronto, Canada

The final, formatted version of the article will be published soon.

Background: Prokineticin 2 is associated with the macrophages-mediated biological process, neuronal death, oxidative stress, and inflammatory processes, while its clinical value in patients with acute ischemic stroke (AIS) has not been explored. This study aimed to evaluate the level of prokineticin 2 and its association with inflammatory indexes and functional recovery in AIS patients.Methods: Serum samples in 210 AIS patients at admission and in 30 healthy subjects at enrollment were collected. Then, prokineticin 2 levels were determined by enzyme-linked immunosorbent assay.Results: Prokineticin 2 level was higher in AIS patients than healthy subjects (P<0.001). Prokineticin 2 showed an acceptable ability to distinguish the AIS patients from healthy subjects (area under the curve: 0.812) with the best cut-off value at 4 ng/ml. No matter dividing the prokineticin 2 by continuous variable or quartiles, its value was positively correlated with the high sensitivity C reactive protein (HsCRP), tumor necrosis factor-alpha (TNF-α), and interleukin 17A (IL-17A) (all P<0.001). Prokineticin 2 showed a higher trend in AIS patients with Modified Rankin Scale (mRS) score>2 compared with those with mRS score≤2, but without statistical significance (P=0.095). Besides, there was no association between prokineticin 2 by quartiles and the percentage of mRS >2 (P>0.05). Conclusion: Prokineticin 2 aberrantly highly expresses, and it indicates the inflammatory status, but with limited ability to predict the neural functional recovery in AIS patients.

Keywords: Acute ischemic stroke, Prokineticin 2, inflammatory status, functional recovery, MRS

Received: 29 Jan 2025; Accepted: 06 Jun 2025.

Copyright: © 2025 Sun, Fu, Yang, Wang, Cui, Feng, Song, Li, Wang, Wang, Wu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jingmei Wang, HanDan Central Hospital, Handan, Hebei Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.